The Human Hippocampus in Parkinson's Disease: An Integrative Stereological and Proteomic Study.

Journal of Parkinson's Disease
Sandra Villar-CondeIsabel Ubeda-Bañon

Abstract

Parkinson's disease (PD) is a prevalent neurodegenerative disease that is pathologically described as a six-stage α-synucleinopathy. In stage 4, α-synuclein reaches the hippocampus, inducing cognitive deficits, from which it progresses to the isocortex, leading to dementia. Among hippocampal fields, cornu ammonis 2 is particularly affected by this α-synucleinopathy and critical for cognitive decline. Volumetric studies using magnetic resonance imaging have produced controversial results, with only some reporting volume loss, whereas stereological data obtained using nonspecific markers do not reveal volume changes, neural or glial loss. Proteomic analysis has not been carried out in the hippocampus of patients with PD. This study aims to explain hippocampal changes in patients with PD at the cellular and proteomic levels. α-Synuclein inclusions, volume and neural (NeuN), microglial (Iba-1) and astroglial (GFAP) populations were stereologically analyzed. SWATH-MS quantitative proteomic analysis was also conducted. Area fraction fractionator probe revealed a higher area fraction α-synucleinopathy in cornu ammonis 2. No volume change, neurodegeneration, microgliosis or astrogliosis was detected. Proteomic analysis identified 1,634...Continue Reading

References

Jun 1, 1990·The Journal of Comparative Neurology·M J West, H J Gundersen
Jan 1, 1994·Acta Neuropathologica·D W DicksonJ Q Trojanowski
Oct 18, 2001·Acta Neuropathologica·A J Harding, G M Halliday
Jan 10, 2002·Annals of Neurology·Antony J HardingGlenda M Halliday
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Jun 20, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Richard CamicioliJeffrey A Kaye
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mahmood Amiry-MoghaddamOle P Ottersen
Jun 26, 2004·Annual Review of Neuroscience·Larry R SquireRobert E Clark
Mar 9, 2005·Trends in Cell Biology·Kenneth S KosikTomoyo Ochiishi
Sep 4, 2007·Progress in Brain Research·Menno P Witter
Dec 11, 2008·Annals of Neurology·Robert E BurkeJean Paul G Vonsattel
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Stephen B SimonsSerena M Dudek
May 4, 2010·Annals of Neurology·Kurt A Jellinger
Jun 18, 2011·Journal of the Neurological Sciences·Eduardo Tolosa, Claustre Pont-Sunyer
Sep 1, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Rachel JamesKaren Horsburgh
Sep 6, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Tracy R MelzerTim J Anderson
Apr 18, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Edward C Lauterbach
Nov 23, 2012·The Journal of Comparative Neurology·Zhenzhong CuiW Scott Young
Nov 28, 2012·Nature Reviews. Neurology·Michel GoedertHeiko Braak
Sep 3, 2013·Journal of Neural Transmission·Richard A ArmstrongNigel J Cairns
Dec 18, 2013·Bioinformatics·Andreas KrämerStuart Tugendreich
Jan 28, 2014·PloS One·Irena RektorovaAngelo Antonini
Apr 24, 2015·Lancet·Lorraine V Kalia, Anthony E Lang
Dec 15, 2015·Neuropathology and Applied Neurobiology·Kelly Del Tredici, Heiko Braak
Jan 26, 2016·Nature Reviews. Neuroscience·Serena M DudekShannon Farris
Mar 19, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Alicia Flores-CuadradoAlino Martinez-Marcos
Jan 1, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David H AdamowiczFred H Gage
Feb 16, 2017·Frontiers in Bioscience (Landmark Edition)·Math P Cuajungco, Kirill Kiselyov
Mar 10, 2017·Brain Research Bulletin·Jacqueline A HubbardDevin K Binder
Mar 24, 2017·Nature Reviews. Disease Primers·Werner PoeweAnthony E Lang
Jul 25, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Su Jin ChungPhil Hyu Lee
Aug 23, 2017·Proceedings of the National Academy of Sciences of the United States of America·Lindsey B SheltonChad A Dickey
Sep 2, 2017·Journal of Neuropathology and Experimental Neurology·Alicia Flores-CuadradoAlino Martinez-Marcos
Jun 3, 2018·Journal of Neural Transmission·Abhishek LenkaPramod Kumar Pal
Jun 6, 2018·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Cindy Chi-Ching PangRaymond Chuen-Chung Chang
Jul 5, 2018·Frontiers in Neurology·Nicolas GiguèreLouis-Eric Trudeau
Sep 28, 2018·Nature Neuroscience·Mathias Jucker, Lary C Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2021 Meta ULC. All rights reserved